PTC Therapeutics (FRA:BH3) Tax Rate %: 14.40% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:BH3 PTC Therapeutics Inc FRA:BH3
62 GF Score
Price €62.62
GF Value €31.64
! 7 Warning Signs
View Full Analysis

What is PTC Therapeutics Tax Rate %?

PTC Therapeutics FRA:BH3 +3.44% 62 Tax Rate % is 14.40% as of Jun. 2026. GuruFocus rates FRA:BH3 with a GF Score™ of 62/100 and a GF Value™ of €31.64. The stock has 7 warning signs investors should review.

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. PTC Therapeutics's Tax Expense for the three months ended in Jun. 2026 was €12.2 Mil. PTC Therapeutics's Pre-Tax Income for the three months ended in Jun. 2026 was €84.7 Mil. Therefore, PTC Therapeutics's Tax Rate % for the quarter that ended in Jun. 2026 was 14.40%.

PTC Therapeutics Tax Rate % Related Terms

PTC Therapeutics Tax Rate % Historical Data

* Premium members only.

The historical data trend for PTC Therapeutics's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PTC Therapeutics Tax Rate % Chart

PTC Therapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Tax Rate %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.07 4.85 9.98 -0.05 2.01

PTC Therapeutics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Tax Rate % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.73 168.89 2.96 -14.08 14.40
FRA:BH3
62GF Score
PTC Therapeutics Inc FRA:BH3
Tax Rate % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PTC Therapeutics Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

PTC Therapeutics's Tax Rate % for the fiscal year that ended in Dec. 2025 is calculated as

Tax Rate %=Tax Expense (A: Dec. 2025 )/Pre-Tax Income (A: Dec. 2025 )
=11.935/594.913
=2.01 %

PTC Therapeutics's Tax Rate % for the quarter that ended in Jun. 2026 is calculated as

Tax Rate %=Tax Expense (Q: Jun. 2026 )/Pre-Tax Income (Q: Jun. 2026 )
=12.195/84.669
=14.40 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Rate % →
What does a Tax Rate % of 14.40% mean?
PTC Therapeutics (FRA:BH3) has a Tax Rate % of 14.40% as of Jun. 2026.
Is PTC Therapeutics' Tax Rate % too high?
PTC Therapeutics' current Tax Rate % is 14.40%. Overall, PTC Therapeutics has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does PTC Therapeutics' Tax Rate % compare to XENE and CGON?
PTC Therapeutics' Tax Rate % of 14.40% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Rate % for a Biotechnology company?
A good Tax Rate % depends on the Biotechnology industry context. However, Tax Rate % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Rate % mean?
A high Tax Rate % can signal that a stock is expensive relative to its fundamentals. PTC Therapeutics's current Tax Rate % is 14.40%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PTC Therapeutics stock overvalued right now?
PTC Therapeutics (FRA:BH3) has a current Tax Rate % of 14.40%. The stock's GF Value™ is €31.64, compared to a current price of €62.62 — trading 97.9% above its estimated fair value. The current Tax Rate % is 14.40%. PTC Therapeutics' overall GF Score™ is 62/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Rate % calculated?
Tax Rate % is calculated from a company's financial statements. For PTC Therapeutics (FRA:BH3), the current Tax Rate % is 14.40% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PTC Therapeutics (FRA:BH3) Overvalued in 2026?

Based on GuruFocus' analysis, PTC Therapeutics stock appears to be overvalued. The current stock price of €62.62 is trading 97.9% above its estimated GF Value™ of €31.64.

Key valuation signals for FRA:BH3:

  • Tax Rate %: 14.40%
  • GF Value™: €31.64 vs. price of €62.62 (97.9% above fair value)
  • GF Score™: 62/100 with 7 warning signs

No single metric tells the full story. See the FRA:BH3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PTC Therapeutics Business Description

Other Exchanges PTCT:USABH3:Germany
Address 500 Warren Corporate Center Drive, Warren, NJ, USA, 07059
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
62GF Score

Get the complete analysis for FRA:BH3

Tax Rate % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€62.62
Price
€31.64
GF Value